Jefferson City Medical Group
Jefferson City, Missouri, United States
Medical clinic in Jefferson City, Missouri
1241 W Stadium Blvd Floor 1, Jefferson City, MO 65109
About Jefferson City Medical Group
"Jefferson City Medical Group is one of Missouri's largest multi-specialty groups. JCMG in Jefferson City, MO grew from the belief that the best medical decisions are made by patients working closely with their physicians. For medical advice, please call your physician."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AstraZeneca
2
Celgene
2
Clinical Trials at Jefferson City Medical Group
During the past decade, Jefferson City Medical Group conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
Amphotericin B Suspension in Refractory Chronic Sinusitis
2006-12-01
2007-10-01
Completed
300
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
2008-01-01
2010-10-01
Completed
148
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)
2008-09-01
2011-04-01
Completed
75
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
2010-07-01
2013-02-01
Completed
2,996
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
2010-10-01
2013-02-01
Completed
2,245
Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
2012-06-17
2016-05-23
Completed
800
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Jefferson City Medical Group" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Celgene" with 2 trials
sponsored, "Novartis" with 2 trials sponsored, "Accentia Biopharmaceuticals" with 1 trials sponsored and "Ayala Pharmaceuticals, Inc,"
with 1 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Jefferson City Medical Group"
#1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator, "Molecular Partners AG" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Jefferson City Medical Group
According to Clinical.Site data, the most researched conditions in "Jefferson City Medical Group" are
"Crohn Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Type 2 Diabetes" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Jefferson City Medical Group" in a lesser frequency.
Clinical Trials Intervention Types at Jefferson City Medical Group
Most popular intervention types in "Jefferson City Medical Group" are "Drug" (17 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Dapagliflozin" (2 trials), "GED-0301" (2 trials), "vildagliptin" (2 trials) and "AL102" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Jefferson City Medical Group
The vast majority of trials in "Jefferson City Medical Group" are
20 trials for "All" genders.
Clinical Trials Status at Jefferson City Medical Group
Currently, there are NaN active trials in "Jefferson City Medical Group".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Jefferson City Medical Group,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Jefferson City Medical Group, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".